Wang, H., Wang, G., Li, T., Zhang, P., Mao, Z., Luo, H., . . . Huang, L. Efficacy and safety of a novel CD19, CD22 dual-targeted fully human loop bi-CAR-T for the treatment of relapsed/refractory B cell non-Hodgkin lymphoma. BMC.
Chicago Style (17th ed.) CitationWang, Hanyu, et al. Efficacy and Safety of a Novel CD19, CD22 Dual-targeted Fully Human Loop Bi-CAR-T for the Treatment of Relapsed/refractory B Cell Non-Hodgkin Lymphoma. BMC.
MLA (9th ed.) CitationWang, Hanyu, et al. Efficacy and Safety of a Novel CD19, CD22 Dual-targeted Fully Human Loop Bi-CAR-T for the Treatment of Relapsed/refractory B Cell Non-Hodgkin Lymphoma. BMC.
Warning: These citations may not always be 100% accurate.